Tumor Biology

, Volume 34, Issue 6, pp 4073–4079 | Cite as

Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer

  • Jing Pei
  • Fang Li
  • Benzhong Wang
Research Article


The onset and development of breast cancer (BC) are influenced by many factors, including the single nucleotide polymorphism (SNP) rs2046210 at 6q25.1. However, studies of the potential association between rs2046210 at 6q25.1 and risk of BC have given inconsistent results. We performed a meta-analysis to address this controversy. PubMed, EMBASE, and Web of Science were systematically searched to identify relevant studies. Odds ratios (ORs) with 95 % confidence intervals (CIs) were calculated to assess the strength of the association between this SNP and risk of BC. A total of 14 studies are included in the meta-analysis, involving 123,085 cases and 120,761 controls. The A-allele, AA/GA, and AA genotypes were significantly associated with increased risk of BC (A-allele vs. G-allele: OR = 1.20, 95%CI = 1.15–1.25, P for heterogeneity < 0.0001; AA/GA vs. GG: OR = 1.22, 95%CI = 1.16–1.28, P for heterogeneity < 0.0001; AA vs. GA/GG: OR = 1.18, 95%CI = 1.13–1.24, P for heterogeneity = 0.064). In further stratified analysis by ethnicity, the elevated risks were found in Europeans and Asians, while there was no significant association detected in African population. In the subgroup analysis based on sample size and source of control, significant results were observed in all the subgroups. There was evidence of heterogeneity (P < 0.10), which largely disappeared after stratification by ethnicity. In summary, this meta-analysis suggests the participation of rs2046210 at 6q25.1 in the susceptibility for BC, especially in Europeans and Asians.


6q25.1 rs2046210 SNP Single nucleotide polymorphism Variant and breast cancer (BC) 


Conflicts of interest


Supplementary material

13277_2013_997_MOESM1_ESM.docx (353 kb)
ESM 1 (DOCX 353 kb)


  1. 1.
    Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56(3):168–83.PubMedCrossRefGoogle Scholar
  2. 2.
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.PubMedCrossRefGoogle Scholar
  3. 3.
    Sturgeon SR, Schairer C, Grauman D, El Ghormli L, Devesa S. Trends in breast cancer mortality rates by region of the United States, 1950–1999. Cancer Causes Control. 2004;15(10):987–95.PubMedCrossRefGoogle Scholar
  4. 4.
    Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85.PubMedCrossRefGoogle Scholar
  5. 5.
    Cheung KL. Endocrine therapy for breast cancer: an overview. Breast. 2007;16(4):327–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Silva Idos S, De Stavola B, McCormack V. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 2008;5(9):e193.PubMedCrossRefGoogle Scholar
  7. 7.
    Zaman K, Bodmer A, Pralong F, Castiglione-Gertsch M. Breast cancer and obesity, a dangerous relation. Rev Med Suisse. 2012;8(342):1101–4.PubMedGoogle Scholar
  8. 8.
    Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol. 2004;15(6):875–84.PubMedCrossRefGoogle Scholar
  9. 9.
    Hankinson SE. Circulating levels of sex steroids and prolactin in premenopausal women and risk of breast cancer. Adv Exp Med Biol. 2008;617:161–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Lux MP, Fasching PA, Beckmann MW. Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med (Berl). 2006;84(1):16–28.PubMedCrossRefGoogle Scholar
  11. 11.
    Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002;31(1):33–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41(3):324–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet. 2009;41(5):585–90.PubMedCrossRefGoogle Scholar
  14. 14.
    Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet. 2010;42(10):885–92.PubMedCrossRefGoogle Scholar
  15. 15.
    Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447(7148):1087–93.PubMedCrossRefGoogle Scholar
  16. 16.
    Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst. 2011;103(5):425–35.PubMedCrossRefGoogle Scholar
  17. 17.
    Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007;39(7):870–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39(7):865–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40(6):703–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41(5):579–84.PubMedCrossRefGoogle Scholar
  21. 21.
    Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504–7.PubMedCrossRefGoogle Scholar
  22. 22.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.PubMedCrossRefGoogle Scholar
  23. 23.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.PubMedGoogle Scholar
  24. 24.
    Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet. 2011;20(16):3304–21.PubMedCrossRefGoogle Scholar
  25. 25.
    Cai Q, Wen W, Qu S, Li G, Egan KM, Chen K, et al. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of Chinese, Japanese, and European ancestry. Cancer Res. 2011;71(4):1344–55.PubMedCrossRefGoogle Scholar
  26. 26.
    Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, et al. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst. 2011;103(16):1252–63.PubMedCrossRefGoogle Scholar
  27. 27.
    Chan M, Ji SM, Liaw CS, Yap YS, Law HY, Yoon CS, et al. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. Breast Cancer Res Treat. 2012;136(1):209–20.PubMedCrossRefGoogle Scholar
  28. 28.
    Han W, Woo JH, Yu JH, Lee MJ, Moon HG, Kang D, et al. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol Biomarkers Prev. 2011;20(5):793–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, et al. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One. 2012;7(8):e42380.PubMedCrossRefGoogle Scholar
  30. 30.
    Jiang Y, Han J, Liu J, Zhang G, Wang L, Liu F, et al. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province. Breast Cancer Res Treat. 2011;128(1):251–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Kim HC, Lee JY, Sung H, Choi JY, Park SK, Lee KM, et al. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res. 2012;14(2):R56.PubMedCrossRefGoogle Scholar
  32. 32.
    Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2011;13(6):R110.PubMedCrossRefGoogle Scholar
  33. 33.
    Ruiz-Narvaez EA, Rosenberg L, Yao S, Rotimi CN, Cupples AL, Bandera EV, et al. Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African–American women. Carcinogenesis. 2013;34(2):287–91.PubMedCrossRefGoogle Scholar
  34. 34.
    Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A, et al. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet. 2010;6(7):e1001029.PubMedCrossRefGoogle Scholar
  35. 35.
    Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res. 2011;71(19):6240–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Sueta A, Ito H, Kawase T, Hirose K, Hosono S, Yatabe Y, et al. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat. 2012;132(2):711–21.PubMedCrossRefGoogle Scholar
  37. 37.
    Cancer CGoHFiB. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.Google Scholar
  38. 38.
    Zuppan P, Hall JM, Lee MK, Ponglikitmongkol M, King MC. Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet. 1991;48(6):1065–8.PubMedGoogle Scholar
  39. 39.
    Russo J, Ao X, Grill C, Russo IH. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat. 1999;53(3):217–27.PubMedCrossRefGoogle Scholar
  40. 40.
    Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol. 2006;102(1–5):89–96.PubMedCrossRefGoogle Scholar
  41. 41.
    Lundstrom E, Sahlin L, Skoog L, Hagerstrom T, Svane G, Azavedo E, et al. Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density. Climacteric. 2006;9(4):277–82.PubMedCrossRefGoogle Scholar
  42. 42.
    Borras M, Hardy L, Lempereur F, el Khissiin AH, Legros N, Gol-Winkler R, et al. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol. 1994;48(4):325–36. 43.PubMedCrossRefGoogle Scholar
  43. 43.
    Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongkol M, Puente M, et al. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol. 1988;2(12):1157–62.PubMedCrossRefGoogle Scholar
  44. 44.
    Li WF, Hou SX, Yu B, Li MM, Ferec C, Chen JM. Genetics of osteoporosis: accelerating pace in gene identification and validation. Hum Genet. 2010;127(3):249–85.PubMedCrossRefGoogle Scholar
  45. 45.
    Xie H, Sun M, Liao XB, Yuan LQ, Sheng ZF, Meng JC, et al. Estrogen receptor alpha36 mediates a bone-sparing effect of 17beta-estrodiol in postmenopausal women. J Bone Miner Res. 2011;26(1):156–68.PubMedCrossRefGoogle Scholar
  46. 46.
    Dunbier AK, Anderson H, Ghazoui Z, Lopez-Knowles E, Pancholi S, Ribas R, et al. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genet. 2011;7(4):e1001382.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.The Department of Breast SurgeryThe First Affiliated Hospital of Anhui Medical UniversityHefeiChina
  2. 2.Shanghai First Maternity and Infant HospitalTongji University School of MedicineShanghaiChina

Personalised recommendations